InsidersTradesSigma
Discover the complete record of transactions filed by Schobel Alexander Mark, Directeur de l'Innovation/Technologie. Officer active across 1 companies, notably Aquestive Therapeutics, Inc.. Cumulatively, 1 disclosures have been recorded. Total volume traded: €41k. The latest transaction was disclosed on 8 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Alexander Mark Schobel is the Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. He is responsible for innovation strategy and managing the company's technologies. With a strong background in the industry, he plays a key role in developing innovative solutions that support Aquestive's growth. His expertise is essential in achieving the organization's objectives.